MSM-165

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMSM-165
Drug Alias NameGPCR antagonist for solid tumor/metastasis(MSM Protein)MSM-165
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionG-protein coupled receptor antagonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsSolid tumoursNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMsm Protein Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMsm Protein Technologies Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A